image
Arcus Biosciences, Inc. RCUS
Healthcare - Biotechnology - NYSE - US
Watchlist
$ 8.09
-2.16 %
$ 856 M
Market Cap
-2.46
P/E
Price Target Average
297.10%
Revenue Forecast Estimate
35.54%
EBIT Estimate
--19.44%
Net Income Estimate
22.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Arcus Biosciences, Inc.
image
Wall Street analysts predict an average 1-year price target for RCUS of $32.1 , with forecasts ranging from a low of $20 to a high of $46 .
RCUS Lowest Price Target Wall Street Target
20 USD 147.22%
RCUS Average Price Target Wall Street Target
32.1 USD 297.10%
RCUS Highest Price Target Wall Street Target
46 USD 468.60%
Price
Max Price Target
Min Price Target
Average Price Target
50504545404035353030252520201515101055Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart RCUS

image
$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RCUS

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RCUS

image
$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029